Carmignac Gestion’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-44,475
Closed -$5.9M – 124
2026
Q2
$5.9M Buy
+44,475
New +$4.01M 0.08% 66

Other funds holding APGE

Carmignac Gestion's APGE Position: Q3 2026 in Review

Carmignac Gestion sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 44,475 shares — an estimated $5.9M sold.

Carmignac Gestion first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $5.9M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

  • Carmignac Gestion reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Carmignac Gestion sold 44,475 Apogee Therapeutics shares in Q3 2026, an estimated $5.9M.
  • Carmignac Gestion first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
  • Carmignac Gestion's Apogee Therapeutics position peaked at $5.9M in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on Carmignac Gestion's 13F filing for Q3 2026, filed 13 Nov 2026.